Pharmaceutical Industry Research Report, Pharma Market

sale

CIS Insulin Market

U

2026

CIS Insulin Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Insulin is a hormone produced by beta cells in the pancreas which regulates the metabolism of carbohydrates & fats in the body. The main function of insulin is ...

Report Code : A00409 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Rapid Acting Insulin Market

P

2021

Rapid Acting Insulin Market: Global Opportunity Analysis and Industry Forecast, 2020–2027

The global rapid acting insulin market size was valued at $7,100 million in 2019, and is projected to reach $8,925 million by 2027 at a CAGR of 4.1% from 2020 to 2027.

Report Code : A10599 | Pages : 168 | Category : Life Sciences

Price:

~~$3,712~~ $2,858 (23% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

sale

Long-acting insulin market by Product Type

U

2026

Long-acting insulin market by Product Type : Global Opportunity Analysis and Industry Forecast, 2023-2032

Insulin moves sugar (glucose) from blood to cells for energy or capacity. On the off chance that you take insulin, you may require some at supper time to ...

Report Code : A13356 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Premix Insulin Market

U

2026

Premix Insulin Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Premixed insulin is a blend of two insulin combined as one, one insulin that is short-acting or effective in addition to one insulin that is halfway acting. The ...

Report Code : A13367 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Insulin Biosimilars Market

U

2026

Insulin Biosimilars Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Biosimilars are biological products that have active properties that are similar to those of a previously licensed drug and have no clinically relevant differences in terms of safety and effectiveness.

Report Code : A14003 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Human Recombinant Insulin Market

P

2024

Human Recombinant Insulin Market: Global Opportunity Analysis and Industry Forecast, 2024 - 2033

The global human recombinant insulin market was valued at $27.6 billion in 2023, and is projected to reach $34.7 billion by 2033, growing at a CAGR of 2.4% from 2024 to 2033.

Report Code : A281792 | Pages : 300 | Category : Life Sciences

Price:

~~$2,655~~ $1,859 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

Pharmaceuticals

Filter by Region

Filter by Discounts

Filter by Category

Insulin is a hormone produced by beta cells in the pancreas which regulates the metabolism of carbohydrates & fats in the body. The main function of insulin is ...

The global rapid acting insulin market size was valued at $7,100 million in 2019, and is projected to reach $8,925 million by 2027 at a CAGR of 4.1% from 2020 to 2027.

Insulin moves sugar (glucose) from blood to cells for energy or capacity. On the off chance that you take insulin, you may require some at supper time to ...

Premixed insulin is a blend of two insulin combined as one, one insulin that is short-acting or effective in addition to one insulin that is halfway acting. The ...

Biosimilars are biological products that have active properties that are similar to those of a previously licensed drug and have no clinically relevant differences in terms of safety and effectiveness.

The global human recombinant insulin market was valued at $27.6 billion in 2023, and is projected to reach $34.7 billion by 2033, growing at a CAGR of 2.4% from 2024 to 2033.